Forman Mark S
- SEC CIK
- 0001922353
No open-market purchases or sales filed in the past year.
Current role at each company
- VTYX Ventyx Biosciences, Inc.Chief Medical Officeras of Mar 4, 2026
- PASG Passage BIO, Inc.CHIEF MEDICAL OFFICERas of Mar 19, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Forman Mark S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PASG Passage BIO, Inc.
CHIEF MEDICAL OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 (view filing) | Feb 13 | Same day | Forman Mark SCHIEF MEDICAL OFFICER | SSale | −1.64K | $0.97 | −$1.59K | −3.3%48.6K after | |
| Jan 3, 2024 (view filing) | Jan 2 | 1 day | Forman Mark SChief Medical Officer | SSale | −15.8K | $0.91 | −$14.4K | −25.9%45.3K after |